1LLY:BIT
Eli Lilly And Co
1 017,40 €
arrow_downward
-0,57%(-5,80) 1D
2 tet, 5:29:23 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 1LLY...
Hap
1 023,60 €
I lartë
1 031,00 €
I ulët
1 016,00 €
Kapitalizimi i tregut
1,11 bln
Vëllimi mesatar
382,00
Vëllimi
492,00
Maksimumi 52-javor
1 106,80 €
Minimumi 52-javor
640,70 €
Numri i punonjësve
50 mijë
Hap
1 023,60 €
I lartë
1 031,00 €
I ulët
1 016,00 €
Kapitalizimi i tregut
1,11 bln
Vëllimi mesatar
382,00
Vëllimi
492,00
Maksimumi 52-javor
1 106,80 €
Minimumi 52-javor
640,70 €
Numri i punonjësve
50 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Insider Monkey
·
4 orë më parë
Eli Lilly (LLY) Posted 48% Revenue Growth. Why Does the Stock Trade Below Its Average Multiple?
24/7 Wall St.
·
1 ditë më parë
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
Investing.com
·
1 ditë më parë
Lilly presents exploratory biomarker data from psoriasis study
Stock Traders Daily
·
1 ditë më parë
Discipline and Rules-Based Execution in LLY Response
Profili
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Rreth Eli Lilly And Co
Drejtori ekzekutivDavid A. Ricks
Punonjësit50 mijë
Themeluar më1876
SeliaIndianapolis, Indiana, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtililly.com